Posts tagged Mizuho


Mizuho Forecasts 127% Upside for Adamas Pharmaceuticals Inc (ADMS) Following Higher-Than-Anticipated Gocovri Pricing

Analyst nearly doubles price target between Gocovri pricing and better prospects in Multiple Sclerosis arena.

Adamas Pharmaceuticals Inc’ (ADMS) Gocovri Has Mizuho Confident Following Favorable Expert Call

Lead asset for ADMS indicates promising prospects in Parkinson’s along with valuable opportunity in MS.

Will Apple Inc. (AAPL) iPhone X Translate to Overall Upside Risk or Reward? Analysts Weigh In

Mizuho expects limited upside potential; Guggenheim lifts price target on AAPL, predicting key upside ahead.

Micron Technology, Inc. (MU) in Good Shape to Ride Stable DRAM Uptrend and Demand

We would be buyers of Micron approaching the FQ3 print and Apple event, says top analyst.

Mizuho Top Analyst Buzzes Mayday as Eagle Pharmaceuticals Inc (EGRX) Valuation Likely to Collapse

Eagle Pharmaceuticals Inc (NASDAQ:EGRX) shares are on an almost 24% cave-in today after the biotech …

Top Analysts Are Bullish as Advanced Micro Devices, Inc. (AMD) Is Boomeranging Right Back

Advanced Micro Devices, Inc. (NASDAQ:AMD) shares are taking off 10% in pre-market trading following a …

Top Analyst Loses Confidence in Horizon Pharma PLC (HZNP)

Horizon Pharma PLC (NASDAQ:HZNP) investors scurried sending shares crashing 35% yesterday once the biotech firm …

Show More